From: Somatic targeted mutation profiling of colorectal cancer precursor lesions
Gene | Adenoma | HP | SSL | Adjusted p value | |||
---|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | ||
APC | 28 | 41.8 | 0 | 0.0 | 1 | 14.3 | 0.016a |
TP53 | 17 | 25.4 | 0 | 0.0 | 1 | 14.3 | 0.816a |
KRAS | 15 | 22.4 | 2 | 12.5 | 0 | 0.0 | > 0.999a |
BRAF | 4 | 6.0 | 3 | 18.8 | 5 | 71.4 | 0.001a |
EGFR | 6 | 9.0 | 1 | 6.3 | 0 | 0.0 | > 0.999a |
FBXW7 | 6 | 9.0 | 0 | 0.0 | 0 | 0.0 | 0.752a |
GNAS | 5 | 7.5 | 0 | 0.0 | 0 | 0.0 | 0.721a |
SMAD4 | 3 | 4.5 | 0 | 0.0 | 0 | 0.0 | > 0.999a |
CTNNB1 | 3 | 4.5 | 0 | 0.0 | 0 | 0.0 | > 0.999a |
PTEN | 2 | 3.0 | 0 | 0.0 | 0 | 0.0 | > 0.999a |
PIK3CA | 1 | 1.5 | 0 | 0.0 | 1 | 14.3 | > 0.999a |
MLH1 | 1 | 1.5 | 0 | 0.0 | 0 | 0.0 | > 0.999a |
IDH2 | 0 | 0.0 | 0 | 0.0 | 1 | 14.3 | > 0.999a |
HRAS | 1 | 1.5 | 0 | 0.0 | 0 | 0.0 | > 0.999a |
FGFR3 | 1 | 1.5 | 0 | 0.0 | 0 | 0.0 | > 0.999a |
ATM | 1 | 1.5 | 0 | 0.0 | 0 | 0.0 | > 0.999a |